Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV

BACKGROUND: A community COVID-19 outbreak caused by the B.1.1.7 SARS-CoV-2 variant occurred in Taiwan in May 2021. High-risk populations such as people living with HIV (PLWH) were recommended to receive two doses of COVID-19 vaccines. While SARS-CoV-2 vaccines have demonstrated promising results in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wang-Da, Pang, Man Wai, Wang, Jann-Tay, Sun, Hsin-Yun, Huang, Yu-Shan, Lin, Kuan-Yin, Wu, Un-In, Li, Guei-Chi, Liu, Wen-Chun, Su, Yi-Ching, He, Pu-Chi, Lin, Chia-Yi, Yeh, Chih-Yu, Cheng, Yu-Chen, Yao, Yi, Chen, Yi-Ting, Wu, Pei-Ying, Chen, Ling-Ya, Luo, Yu-Zhen, Chang, Hsi-Yen, Sheng, Wang-Huei, Hsieh, Szu-Min, Chang, Sui-Yuan, Hung, Chien-Ching, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745965/
https://www.ncbi.nlm.nih.gov/pubmed/36531082
http://dx.doi.org/10.1016/j.jve.2022.100308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745965/
https://www.ncbi.nlm.nih.gov/pubmed/36531082
http://dx.doi.org/10.1016/j.jve.2022.100308

Ejemplares similares